We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+22.23%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$18.5B
AUM Growth
+$2.83B
Cap. Flow
+$342M
Cap. Flow %
1.85%
Top 10 Hldgs %
16.55%
Holding
2,427
New
891
Increased
366
Reduced
546
Closed
599

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$163M
2
CCL icon
Carnival Corporation Ltd
CCL
+$137M
3
RGEN icon
Repligen
RGEN
+$104M
4
BIIB icon
Biogen
BIIB
+$104M
5
ZTS icon
Zoetis
ZTS
+$91.9M

Sector Composition

Rank Sector Weight
1 Healthcare 28.24%
2 Consumer Discretionary 12.89%
3 Financials 10.77%
4 Technology 9.62%
5 Industrials 4.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARKF icon
1726
ARK Blockchain & Fintech Innovation ETF
ARKF
$742M
$218K ﹤0.01%
4,390
-14,459
-77% -$652K
INFU icon
1727
InfuSystem Holdings
INFU
$189M
$217K ﹤0.01%
11,564
-6,233
-35% -$93.9K
SHI
1728
DELISTED
Sinopec Shanghai Petrochemical Co., Ltd.
SHI
$217K ﹤0.01%
+10,567
New +$215K
IVC
1729
DELISTED
Invacare Corporation
IVC
$215K ﹤0.01%
23,979
+3,467
+17% +$28.8K
HLLY icon
1730
Holley
HLLY
$319M
$213K ﹤0.01%
+21,231
New +$211K
CLDX icon
1731
Celldex Therapeutics
CLDX
$2.8B
$211K ﹤0.01%
+12,023
New +$216K
MLCO icon
1732
Melco Resorts & Entertainment
MLCO
$2.18B
$210K ﹤0.01%
11,303
-216,018
-95% -$3.76M
RAMP icon
1733
LiveRamp
RAMP
$2.3B
$210K ﹤0.01%
2,866
-21,647
-88% -$1.38M
URA icon
1734
Global X Uranium ETF
URA
$5.6B
$210K ﹤0.01%
+13,701
New +$168K
KIDS icon
1735
OrthoPediatrics
KIDS
$509M
$207K ﹤0.01%
+5,007
New +$230K
SOHU
1736
Sohu.com
SOHU
$345M
$207K ﹤0.01%
+12,988
New +$238K
USIO icon
1737
Usio Inc
USIO
$53.3M
$207K ﹤0.01%
+77,678
New +$138K
GSM icon
1738
FerroAtlántica
GSM
$617M
$203K ﹤0.01%
+123,822
New +$130K
SRE icon
1739
Sempra
SRE
$59.7B
$202K ﹤0.01%
+3,170
New +$204K
ACIW icon
1740
ACI Worldwide
ACIW
$5.88B
$201K ﹤0.01%
5,239
-230,016
-98% -$7.71M
HBB icon
1741
Hamilton Beach Brands
HBB
$300M
$201K ﹤0.01%
11,467
-2,577
-18% -$50.7K
ROG icon
1742
Rogers Corp
ROG
$2.31B
$201K ﹤0.01%
1,294
-8,727
-87% -$1.16M
WELL icon
1743
Welltower
WELL
$175B
$201K ﹤0.01%
+3,113
New +$189K
DGNR.WS
1744
CALL
DELISTED
Dragoneer Growth Opportunities Corp. Redeemable warrants, each whole warrant exercisable for one Cla
DGNR.WS
$199K ﹤0.01%
+14,999
New +$49.4K
MTDR icon
1745
Matador Resources
MTDR
$5.86B
$197K ﹤0.01%
16,327
-31,114
-66% -$304K
DFIN icon
1746
Donnelley Financial Solutions
DFIN
$1.26B
$193K ﹤0.01%
11,395
-91,705
-89% -$1.42M
SHSP
1747
DELISTED
SharpSpring, Inc.
SHSP
$183K ﹤0.01%
+11,231
New +$156K
MSGN
1748
DELISTED
MSG Networks Inc.
MSGN
$180K ﹤0.01%
+12,192
New +$136K
RCHG
1749
DELISTED
Recharge Acquisition Corp. Class A Common Stock
RCHG
$179K ﹤0.01%
+17,543
New +$175K
ATNM icon
1750
Actinium Pharmaceuticals
ATNM
$26.8M
$178K ﹤0.01%
+22,842
New +$248K

Similar funds

Marshall Wace's Q4 2020 Portfolio in Review

As of Q4 2020, Marshall Wace held 2,427 positions worth $18.5B, up 18% from $15.6B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Marshall Wace's Q4 2020 filing shows 891 new, 366 increased, 546 reduced and 599 closed positions. Its largest new stake was Natera: 911,254 shares worth $90.7M. The largest sale was Alphabet (Google) Class A, an estimated $173M.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 24% a quarter earlier, followed by Consumer Discretionary and Financials.

  • Marshall Wace's largest Q4 2020 buy was Natera: 911,254 shares worth $90.7M.
  • Marshall Wace added most to Thermo Fisher Scientific in Q4 2020, an estimated $163M increase.
  • Marshall Wace's biggest Q4 2020 reduction was Alphabet (Google) Class A, cutting an estimated $173M.
  • Marshall Wace fully exited FedEx in Q4 2020, selling an estimated $69.6M.
  • Marshall Wace's ten largest holdings make up 17% of its $18.5B portfolio in Q4 2020.
  • Marshall Wace opened 891 new positions and closed 599 in Q4 2020.
  • Marshall Wace's portfolio value rose 18% quarter-over-quarter to $18.5B.

Based on Marshall Wace's 13F filing for Q4 2020, filed 16 Feb 2021.